Work

Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma.

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.1183.1183

Authors: Robert F. Manges, Heather J. Sutherland, Sundar Jagannath, Robert Z. Orlowski, David La Police, Mark DeWitte, Zhihui Lang, Robert E. Corringham, Jean Francois Rossi

Institutions: Vancouver General Hospital, Saint Vincent's Catholic Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Centre Hospitalier Universitaire de Montpellier

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4247934501

FWCI: 0.621

Cites:

Cited by: 3

Related to: 10